Artificial Intelligence Model Predicts Kidney Graft Survival
THURSDAY, Oct. 24, 2024 -- The U.K. Deceased Donor Kidney Transplant Outcome Prediction (UK-DTOP) model, developed using advanced artificial intelligence, demonstrates superior calibration and discrimination for predicting kidney graft survival, according to a study published online Oct. 22 in Renal Failure.
Hatem Ali, from University Hospitals of Coventry and Warwickshire in the United Kingdom, and colleagues analyzed data from the U.K. Transplant Registry, including 29,713 transplant cases between 2008 and 2022, to assess the predictive performance of the XGBoost, Random Survival Forest, and Optimal Decision Tree machine learning models.
The researchers found that XGBoost demonstrated exceptional performance, with the highest concordance index (0.74) and an area under the curve consistently above 0.73. Compared with the traditional Kidney Donor Risk Index, which achieved a concordance index of 0.57, the UK-DTOP model exhibited marked improvement. Calibration assessments using the Integrated Brier Score further highlighted the advanced capabilities of the XGBoost model, showing a score of 0.14, indicating precise survival probability predictions. Five distinct clusters were identified based on donor and transplant characteristics using unsupervised learning via k-means clustering; significant survival outcome variations were confirmed across the clusters in further analysis using Bayesian Cox regression.
"Our findings suggest that kidney allocation policies should be updated to include more detailed risk stratification," the authors write. "This could lead to advanced models that better account for donor complexity, improve transplant outcomes, and aid in better decision-making when accepting organ offers."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Lung Cancer Screening Beneficial to Age 80 for Candidates Fit for Surgery
FRIDAY, Sept. 12, 2025 -- People aged 75 to 80 years at last screen who are diagnosed with screen-detected lung cancer (LC) have lower overall survival, but those undergoing...
Sex Differences Seen in Characteristics, Course of Schizophrenia, Bipolar Disorder
FRIDAY, Sept. 12, 2025 -- Significant sex differences are seen in the characteristics and course of schizophrenia (SZ) and bipolar disorder (BD), according to a study published...
Potentially Inappropriate Medications Linked to Frailty at Cancer Diagnosis
FRIDAY, Sept. 12, 2025 -- For patients with newly diagnosed cancer, an increasing number of potentially inappropriate medications (PIMs), as identified by the Geriatric Oncology...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.